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In wound repair vimentin mediates the transition
of mesenchymal leader cells to a myofibroblast
phenotype
J. L. Walker*, B. M. Bleaken, A. R. Romisher, A. A. Alnwibit, and A. S. Menko*
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107

ABSTRACT Following injury, mesenchymal repair cells are activated to function as leader
cells that modulate wound healing. These cells have the potential to differentiate to myofibroblasts, resulting in fibrosis and scarring. The signals underlying these differing pathways
are complex and incompletely understood. The ex vivo mock cataract surgery cultures are an
attractive model with which to address this question. With this model we study, concurrently,
the mechanisms that control mesenchymal leader cell function in injury repair within their
native microenvironment and the signals that induce this same cell population to acquire a
myofibroblast phenotype when these cells encounter the environment of the adjacent tissue
culture platform. Here we show that on injury, the cytoskeletal protein vimentin is released
into the extracellular space, binds to the cell surface of the mesenchymal leader cells located
at the wound edge in the native matrix environment, and supports wound closure. In profibrotic environments, the extracellular vimentin pool also links specifically to the mesenchymal
leader cells and has an essential role in signaling their fate change to a myofibroblast. These
findings suggest a novel role for extracellular, cell-surface–associated vimentin in mediating
repair-cell function in wound repair and in transitioning these cells to a myofibroblast
phenotype.

INTRODUCTION
In the normal repair process, mesenchymal cell populations restore
tissue function in response to tissue insult or injury; however, their
susceptibility to becoming myofibroblasts results in a response that
promotes and sustains the fibrotic disease process. Fibrosis is a devastating progressive disease, its pathology characterized by the excessive production of extracellular matrix proteins like collagen I,
with myofibroblasts being a major producer of this fibrosis-causing
matrix. Fibrosis affects almost every organ of the body, causing irreparable damage wherever it occurs (Carver and Goldsmith, 2013).
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As fibrosis is an outcome of so many distinct disease states, it is
considered a leading cause of death (Tsou et al., 2014).
Factors currently known to induce specific aspects of the fibrotic
response to injury repair or pathogenesis include mechanotransduction-signaling events that involve integrin receptors, the actin cytoskeleton, TGFβ, and collagen I (Schwartz, 2010; Huang et al., 2012;
Wong et al., 2012; Duscher et al., 2014; Hinz, 2015). However, it
remains unclear how cells normally tasked with directing wound
repair are signaled to alter their fate and differentiate to myofibroblasts, the cell type associated with fibrosis. Key features of myofibroblast differentiation include 1) high levels of expression of the
intermediate filament protein vimentin, a mediator of cell migration
and wound repair; 2) expression of α-smooth muscle actin (αSMA)
and its organization into the stress fibers that mediate myofibroblast
contractile function; and 3) production of extracellular matrix proteins such as collagen I that are secreted into the extracellular milieu.
These myofibroblast properties create an aberrant microenvironment that leads to loss of tissue function.
Vimentin has emerged as a critical regulator of the wound-
healing process in many distinct tissues and cell types. In studies of
skin wound–repair, this protein has been demonstrated to function as a signaling integrator in tissue regeneration and healing
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(Cheng et al., 2016). Our own studies with an ex vivo, mock-cataract-surgery (MCS), epithelial wound–healing model have shown
that vimentin is a defining characteristic of a resident mesenchymal
“repair” cell population (Walker et al., 2010) that is located in niches
among the cells of the lens equatorial epithelium. This mesenchymal cell population is activated on wounding to immediately migrate to and populate the leading edge of the injured epithelium
(Walker et al., 2010; Menko et al., 2014a). Vimentin is required for
the function of this mesenchymal leader cell population in directing
the collective migration of the injured epithelium to close the wound
(Walker et al., 2010; Menko et al., 2014a). Furthermore, we have
found that when these cells are activated by wounding, they are also
conferred with the ability to invade, a phenotype that is also dependent on vimentin (Bleaken et al., 2016). This finding is consistent
with other studies showing that vimentin is required for an invasivecell phenotype (Satelli and Li, 2011).
Here we investigate whether the properties of vimentin that confer leader cells with the ability to modulate wound repair and direct
invasion also make these cells vulnerable to environmental factors
that can alter their differentiation pathway to that of a myofibroblast.
Other studies have linked vimentin intermediate filaments to the
development of fibrosis. Mice lacking vimentin have exhibited both
reduced scarring following corneal injury (Bargagna-Mohan et al.,
2012) and a diminished fibrotic response to bleomycin-induced
injury of the lung (dos Santos et al., 2015). However, the role of
vimentin in inducing the fibrotic response and the specific features
of vimentin that are associated with the fibrotic phenotype are not
yet clear.
While long understood for their role as a highly stable, stressresistant cytoskeleton, vimentin intermediate filaments are now appreciated as highly dynamic structures that exist in distinct assembly
states and subcellular distributions that define their functions
(Lowery et al., 2015; Herrmann and Aebi, 2016). The different states
of vimentin organization range from nonfilamentous precursors to
unit filaments to a highly organized cytoskeletal network, each with
distinct cellular tasks (Herrmann et al., 2009; Lowery et al., 2015;
Herrmann and Aebi, 2016). Soluble forms of vimentin are associated
with signaling (Perlson et al., 2005), while an organized vimentin
cytoskeletal network is critical to processes such as resisting stress
and providing cell shape (Goldman et al., 2012). The assembly state
of vimentin is regulated through posttranslational modifications
(PTMs) that also modulate vimentin function. Two key PTMs linked
to increased vimentin solubility are phosphorylation and citrullination (deimination). Some of the phosphorylation PTMs are known to
trigger disassembly of intermediate filaments (Ando et al., 1989).
Vimentin citrullination, which results from the conversion of an arginine to a citrulline by peptidyl arginine deiminase (PAD) enzymes,
prevents vimentin assembly and promotes vimentin filament disassembly (Inagaki et al., 1989). In its soluble form, vimentin can function as an extracellular molecule that has been implicated in the
repair process, as shown in a spinal cord injury model (Teshigawara
et al., 2013; Shigyo et al., 2015; Shigyo and Tohda, 2016), and in
modulating macrophage function in bacteria killing (Mor-Vaknin
et al., 2003). In studies with our ex vivo MCS-wounded-explant cultures, a model that closely replicates the features of wound repair in
vivo, we now investigate how a resident mesenchymal repair cell
population that modulates repair of the injured lens epithelium can
become misdirected and become an underlying cause of the aberrant wound-healing response of fibrosis. We show, for the first time,
a role for extracellular vimentin in promoting the differentiation of
these mesenchymal repair cells to the myofibroblast phenotype
associated with fibrosis.
1556 | J. L. Walker et al.

RESULTS
Resident repair cells of the lens direct wounded lens
epithelial cells to migrate off their endogenous basement
membrane and across an adjacent tissue culture substrate
Our studies investigate how mesenchymal leader cells, whose normal role it is to direct regenerative repair of epithelia following
wounding, can be induced to differentiate to myofibroblasts. They
were conducted with the ex vivo MCS culture model we originally
established to investigate mechanisms of wound repair (Walker
et al., 2007, 2010, 2015; Menko et al., 2014a). This wound model
has clinical relevance to fibrosis, as cataract surgery often elicits a
fibrotic response, resulting in the disease known as posterior capsule opacification (PCO) (Wormstone et al., 2009; Wormstone and
Eldred, 2016; Nibourg et al., 2015). We focus on the resident
population of vimentin-rich, mesenchymal repair cells of the lens
that, on MCS injury, are activated to migrate to and rapidly populate the wound edge of the lens epithelium (Figure 1A, D1 postinjury, repair cells at the MCS wound edge colored purple, arrow)
(Walker et al., 2010). Here, functioning as classical leader cells,
these cells direct regenerative repair of the injured epithelium, a
task that is vimentin dependent (Menko et al., 2014a; Bleaken
et al., 2016).
To create these cultures, the MCS-wounded lens is flattened on
a tissue culture substrate by making cuts through the epithelium
and its associated basement membrane, creating the star-shaped
wounded-explant cultures. The cuts made to flatten the explants
are additional injury sites that form the outside edge of the explant. These sites of injury are also rapidly populated by the
wound-activated resident mesenchymal repair cells (Figure 1A,
repair cells at the cut edge colored purple, arrowheads). These
mesenchymal cells lead the lens epithelial cells from their original
position on their native lens basement membrane capsule onto
and across the adjacent, rigid tissue culture substrate. We refer to
the region on the tissue culture plastic that the cells occupy postwounding as the extracapsular zone (ECZ). Formation of the ECZ
in response to injury is best observed by time-lapse microscopy
(Supplemental Video 1, representative still images shown in Figure
1, Bi–Biii). Live imaging revealed that the mesenchymal cells at the
leading edge extend and retract lamellipodial protrusions along
the substrate as they lead the forward movement of the wounded
epithelium across the culture substrate. This behavior closely parallels the injury response we have observed for these resident repair cells previously, when they populate the leading edge of the
MCS-wound and direct wound closure on the endogenous basement membrane substrate of the lens (Menko et al., 2014a;
Bleaken et al., 2016).
We have shown previously that vimentin is a principal characteristic of the repair cells that direct wound closure at the MCS
wound edge (Menko et al., 2014a). Here we examined whether
vimentin was also a defining feature of the repair cells in their
function as leader cells of the ECZ. Following immunolabeling
for vimentin at D2 postinjury, the MCS-wounded-explant cultures
were imaged in regions of the ECZ typical of the boxed area in
Figure 1Biii. The leading-edge cells of the ECZ expressed high
levels of vimentin, prominently localized to the lamellipodial
protrusions that extend along their substrate surface (Figure 1, C
and D, arrows). The organization of vimentin in these cells was
examined in cultures fixed with either formaldehyde (Figure 1, C
and E) or methanol (Figure 1, D and F), and the cells were imaged by both confocal (Figure 1, C and D) and superresolution
confocal (Figure 1, E and F) microscopy. Methanol fixation, which
extracts membrane lipids, highlighted the organized vimentin
Molecular Biology of the Cell

cytoskeleton in the leader cell population.
Immunostaining of formaldehyde fixed
cultures, permeabilized with Triton X-100
postfixation, revealed both a diffuse pattern of vimentin labeling and organized
vimentin filaments. This suggests that
formaldehyde fixation may enhance preservation of soluble vimentin populations.
We have shown previously that another
defining feature of the vimentin-rich, leader
cell population activated in response to
MCS wounding was its expression of CD44
(Bleaken et al., 2016). While widely expressed, this cell-surface receptor for hyaluronic acid (HA) is characteristic of leukocytes and known for its role in cell adhesion
and migration (McDonald and Kubes, 2015;
Bano et al., 2016; Senbanjo and Chellaiah,
2017). Immunolabeling of the woundedlens explant cultures with an antibody to the
CD44 extracellular domain at D2 postinjury
showed that, in the ECZ, CD44 is expressed
exclusively by the repair cells at the leading
edge (Figure 1G, arrow). CD44 is enriched
at the plasma membrane of these leader
cells, especially along their cell borders (arrowhead), and was not expressed by the
lens epithelial cells that migrate behind the
CD44+/vimentin+ leader cell population of
the ECZ.

αSMA+ myofibroblasts appear at the
leading edge of the ECZ, with their
emergence linked to rigidity of the
microenvironment

FIGURE 1: Properties of leader cells activated on injury when they encounter a profibrotic
microenvironment. (A) Ex vivo wound healing/fibrosis culture model, created by performing
mock cataract surgery on isolated chick embryo lenses, which removes the lens fiber cell mass
from the lens native basement membrane (BM) capsule (*). Mesenchymal repair cells (shaded
purple) migrate to both the leading edge of the MCS wound (arrow) and to the cut edges
created to flatten the lens capsule on the substrate (arrowhead). Repair cells at the cut edge
lead the lens epithelium off the lens capsule onto and across the rigid tissue culture substrate,
referred to the extracapsular zone (ECZ). (Bi–Biii) Representative still images from a time-lapse
movie (Supplemental Video 1) taken over 3 d postinjury show the collective migration of the
lens epithelial cells across the ECZ led by mesenchymal leader cells (arrow). The dotted white
line in i, ii, and iii indicates the border of the native capsule and the ECZ. (C–F) Ex vivo MCS
wounded-explant cultures were fixed in formaldehyde (C, E) or in methanol (D, F) 2 d
postinjury, labeled for vimentin, and imaged by confocal microscopy (C, D) or superresolution
confocal microscopy (E, F) in the ECZ, in a region similar to the boxed area in Bii. Vimentin was
enriched in the lamellipodial protrusions extended by leader cells (C–F, arrows). When cultures
were fixed with formaldehyde, both filamentous and diffuse populations of vimentin were
observed at the tips of lamellipodia extensions (C, E, arrow). Methanol fixation conditions
highlighted the vimentin cytoskeleton (D, F). (G) At 2 d postinjury the ex vivo explant cultures
were labeled for CD44 and imaged by confocal microscopy in the ECZ. Mesenchymal leader
cells were distinguished by their expression of the CD44 receptor (arrow), which was enhanced
at cell borders (arrowhead). Magnification (Mag) bars = 20 µm. Images in C–G are presented as
projections.
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Substrate rigidity is a known factor in inducing cells that mediate regenerative repair to become myofibroblasts (Arora et al.,
1999; Li et al., 2007; Liu et al., 2010;
O’Connor et al., 2015). Reprogramming of
cells to a myofibroblast phenotype is characterized by the induction of αSMA and its
organization into stress fibers (Skalli et al.,
1989; Schmitt-Graff et al., 1994). Western
blot analysis of protein extracts from cells
isolated from the ECZ of MCS-woundedexplant cultures from D1 to D6 postinjury
showed that αSMA was first expressed by
ECZ cells at culture D3 and increased
greatly by D6 (Figure 2A). Since the ECZ is
composed of both lens epithelial cells and
the lens-resident, vimentin-rich repair cells
that populate the wound edge postinjury,
we performed immunofluorescence analysis to determine where in the ECZ the
αSMA-expressing cells were localized.
Confocal image analysis at culture D3 revealed that αSMA stress-fiber-positive
myofibroblasts emerged exclusively at the
leading edge of the ECZ (Figure 2, B and
C), the area populated by the vimentin-rich

Vimentin promotes fibrosis
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FIGURE 2: Myofibroblasts emerge at the leading edge of the ECZ and their differentiation is
influenced by the rigidity of the microenvironment. (A) Total cell lysates prepared from isolated
ECZ regions at D1–D3, and D6 were immunoblotted for αSMA, with GAPDH as loading control.
Results were quantified for three independent experiments and presented as a ratio of αSMA to
GAPDH for each fraction. Results demonstrate that αSMA is first expressed on D3 and
increases threefold by D6. (B–E, H) Ex vivo explant cultures were fixed D3 (B, C, H) and D6
(D, E) postinjury and labeled for αSMA (B–E, H). In C, E, and H αSMA is green and F-actin is red.
Cultures were imaged by confocal microscopy in the ECZ (B–E) or on the native capsule (H).
αSMA-positive myofibroblasts emerged at the leading edge of the ECZ at D3 (B, C, arrows)
and by D6 myofibroblasts had expanded in number and formed extensive αSMA stress fibers
(D, E). (F) To examine induction of myofibroblast differentiation in a physiological relevant
profibrotic microenvironment, the ex vivo MCS-wounded explants were cultured for 3 d
postinjury on 2.5 mg/ml collagen gels, corresponding to 25 kPa, and immunolabeled for αSMA.
The result shows that leader cells are induced to acquire a myofibroblast phenotype in a
microenvironment within the physiological range of fibrotic tissues. In contrast, few αSMA+ cells
were observed on the native capsule at culture D3 (H), at which time wound healing was just
completed (G, white box). Results show that the rigidity of the tissue culture substrate is a factor
in the induction of myofibroblast differentiation. The results presented represent a minimum of
three independent studies. Mag bar = 20 µm; images in B–E and G are presented as projections.
Image in H is presented as single optical section.

leader cells (Figure 1, C and D). The presence of myofibroblasts at
the leading edge of the ECZ had increased greatly by D6 postwounding (Figure 2, D and E), in part due to their proliferation
(Supplemental Figure 1).
1558 | J. L. Walker et al.

We also examined whether a substrate in
the physiological range of a profibrotic tissue (Wells, 2013) induces repair-modulating
cells to alter their fate to differentiate into a
myofibroblast phenotype. The ex vivo, MCSwounded explants were placed on tissue
culture dishes coated with collagen I gels of
2.5 mg/ml, corresponding to a Young’s modulus of 25 kPa to examine whether rigidity of
the microenvironment is a factor in inducing
cells involved in repair of the wounded-lens
epithelium to alter their fate and differentiate to myofibroblasts. The stiffness of the
collagen gel is in range of the rigidity of
fibrotic tissues (Wells, 2013). Appearance of
myofibroblasts in the ECZ of MCS-wounded
explants cultured on the collagen I gel substrates was determined by confocal microscopy imaging following immunolabeling for
αSMA. The results show that on collagen
gels of 25 kPa, the leading-edge cells had
differentiated to αSMA+ stress-fiber–containing myofibroblasts on D3 (Figure 2F).
The ex vivo MCS-injury model provides a
unique opportunity to follow, concurrently,
the function of resident repair cells in regulating wound healing in their native microenvironment and how these same repair-modulating cells may be induced to differentiate
to myofibroblasts in the controlled environment of the ECZ. Therefore, we examined
whether myofibroblasts also appeared on
the native lens basement membrane capsule
undergoing regenerative repair post-MCS
(Figure 2, G and H). In contrast to the induction of myofibroblasts on the ECZ substrates,
very few αSMA+ cells were induced to form
on the native substrate of the explant where
the mesenchymal leader cells effectively
direct closure of the lens epithelial wound
by culture D3.

Resident lens mesenchymal cells
activated to modulate repair of the
wounded lens epithelium are
myofibroblast progenitors

Cell fate–tracking studies were performed to
examine whether the leader cells of the ECZ
had the potential to become myofibroblasts.
This approach took advantage of our ability
to specifically tag the vimentin-rich repair
cells at the leading edge of the ECZ with the
extracellular domain CD44 antibody (Figure
1G). For these studies, the mesenchymal
leader cells were tagged with the CD44 antibody by live labeling for 20 min at D1 post
injury. Then the cultures were grown through
culture D3 when myofibroblasts first appear
in the ECZ. To determine whether the cells labeled with CD44 at D1
had differentiated to myofibroblasts at D3, the cultures were fixed,
the CD44-antibody-tagged cells labeled with a fluorescent-labeled
secondary antibody, and the cells in the ECZ coimmunolabeled for
Molecular Biology of the Cell

As an alternative approach, we used a
Boyden chamber invasion assay to examine the potential of vimentin-rich repair
cells to differentiate to myofibroblasts. We
have previously used this assay to reveal
the invasive properties of the CD44+/
vimentin+ mesenchymal subpopulation of
the lens following their activation by MCS
injury (Bleaken et al., 2016). For these studies, MCS-wounded-explant cultures are
placed, cell-side down, on the Matrigelcoated filter of the top Boyden chamber
immediately postinjury. Serum-free medium was placed in the top chamber and
serum-containing medium in the bottom
chamber. As shown in our previous study,
at D2 postinjury the wound-activated
CD44+/vimentin+ repair cells have invaded
through Matrigel to the bottom filter surface of the Matrigel-coated transwell
chamber (Figure 3G). The wounded-lens
epithelial cells remain associated with their
native basement membrane capsule in the
top chamber (Bleaken et al., 2016). The
vimentin-rich leader cells activated following injury that had invaded to the bottom
of the Boyden chamber filter were fixed at
culture D10 and immunolabeled for αSMA.
Confocal image analysis showed that these
cells expressed both vimentin and αSMA
(Figure 3, H and I), evidence that the vimentin+/CD44+ repair cells of the lens can
be targeted to become myofibroblasts.

FIGURE 3: CD44 positive leader cells are precursors of myofibroblasts. (A–F) ECZ cells were live
labeled for 20 min at D1 postinjury with antibody to the cell surface antigen CD44 (A–C) or an
isotype antibody control (D–F). (A–C) The fate of the antibody-tagged cells was followed for 2
more days until myofibroblasts first emerge, at which point the cultures were fixed and the
CD44-tagged cells detected with fluorescent-tagged secondary antibody, the cells colabeled for
αSMA and imaged by confocal microscopy. (D–F) Control study in which cells were labeled with
an isotype control antibody and then treated under the same experimental conditions as in A–C.
(G–I) Ex vivo MCS explants were placed cell side down in the top chamber of Matrigel transwell
invasion chambers, and the properties of the cells that had invaded to the filter side facing the
bottom chamber determined by immunofluorescence analysis. (G) At 2 d postinjury, the
wound-activated CD44+/vimentin+ leader cells had invaded through the Matrigel and populated
the bottom side of the filter, confirming the efficacy of this approach to isolate the repair cell
population. (H, I) The cells on the bottom filter were cultured through D10 postinjury and the cells
co-immunolabeled for vimentin and αSMA. The results show that the wound-activated repair cells
that had invaded to the bottom filter were αSMA+, demonstrating that they had acquired a
myofibroblast phenotype. Together these studies show that the CD44+/vimentin+ leader cell
population activated on injury are myofibroblast progenitors. A–F, Mag bar = 10 µm. G–I, Mag
bar = 20 µm. Images shown are single optical sections (A–F, H, and I) or projections (G).

αSMA. Confocal image analysis showed that all αSMA+ stress-fiberexpressing cells in the ECZ were positive for CD44 (Figure 3, A–C,
arrow). As a control, the cultures were labeled with a nontargeting
immunoglobulin G (IgG) of the same isotype as the CD44 antibody.
The αSMA+ cells that emerge in these control cultures were not labeled by the nontargeting IgG (Figure 3, D–F), confirming the specificity of the CD44-tracking studies. These results demonstrate that
the CD44+ leader cells, a vimentin-rich cell population, are progenitors of the αSMA+ myofibroblasts that emerge in the ECZ in response to wounding.
Volume 29 July 1, 2018

Distinct organization of actin and
vimentin when leader cells are in
located in proregenerative and
profibrotic microenvironments

We found that rigidity is a factor in inducing
wound-activated resident repair cells of the
lens to become myofibroblasts (Figure 2).
This suggests that the change in their differentiation state involves a mechanotransduction-signaling event. The cytoskeleton is a
key factor in transmitting mechanotransduction signals. Therefore, we compared the
organization of the actin and vimentin cytoskeletons in wound-activated repair cells at
the leading edge of the MCS wound on the
native lens basement membrane capsule to
their organization in the leading-edge cells
of the ECZ that forms on the tissue-culture
substrate. The cultures were colabeled with antibody to vimentin and
with fluorescent-tagged phalloidin that labels F-actin. Cytoskeletal
organization was analyzed by confocal microscopy imaging (Figure
4, A–F). The vimentin-rich repair cells at the leading edge of the
wound on the cells’ endogenous basement membrane capsule have
a well-organized vimentin cytoskeleton (Figure 4, A and C, D1), but
this leading-edge population is remarkably F-actin poor (Figure 4, B
and C). In contrast, there is a significant population of vimentin that
is unorganized in the repair cells at the leading edge of the ECZ,
most highly localized to lamellipodial processes these cells extend
Vimentin promotes fibrosis
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Increase in vimentin solubility
postwounding precedes leader cell
differentiation to myofibroblasts

FIGURE 4: Distinct organization of vimentin and actin filaments when leader cells are in
proregenerative and profibrotic microenvironments. (A–F) Ex vivo MCS wounded-explant
cultures were labeled for vimentin (A, C, D, F; green in C, F) and F-actin (B, C, E, F; red in C, F)
on day 1 (A–C) and day 2 (D–F) postinjury, and imaged by confocal microscopy. Vimentin-rich
leader cells at the MCS wound edge on the lens native basement membrane capsule exhibited a
highly organized vimentin cytoskeleton (A, C) but were notably poor in F-actin (B, C). In contrast,
in leader cells associated with the profibrotic environment of the ECZ there was a prominent
population of vimentin with a diffuse labeling pattern that was highly enriched at the tips of
lamellipodial extensions extended along the tissue culture substrate of the ECZ, in additional to
a more classical vimentin cytoskeletal network (D, F). These cells contained abundant F-actin
stress fibers (E, F). (G) Solubility of vimentin was determined at the time of wounding and in the
ECZ cells on D2 postinjury. Cells were extracted sequentially in Triton X-100/octyl glucoside
(Triton/OG) and SDS-containing solutions to separate the soluble vimentin populations,
including unassembled vimentin and short vimentin filaments, from the highly insoluble vimentin
cytoskeleton. Extracts were immunoblotted for vimentin and GAPDH and the percentage of
total vimentin (G) in each fraction was quantified over three independent experiments. Results
show that at the time of wounding vimentin was largely a detergent-insoluble cytoskeletal
network, in contrast to its largely soluble state of organization in the ECZ at D2 postinjury, a
finding consistent with the diffuse state of organization of vimentin in leader cells of the ECZ at
this time (D, F). GAPDH fractionated with the Triton/OG soluble fraction. The histogram shows
the percentage of vimentin ± SEM. The p values were generated by Student’s t test, *p < 0.05,
***p < 0.001. Mag bar = 20 µm. Images in A–F are presented as projections.

along the substrate surface (Figure 4, D and F, D2). In contrast to the
MCS-wound edge, the leading-edge cells in the ECZ are rich in actin
stress fibers (Figure 4, E and F).
1560 | J. L. Walker et al.

The diffuse vimentin-labeling pattern in the
lamellipodia of the highly migratory reparative cells at the leading edge of the ECZ
indicated that the organization of this vimentin population was distinct from the
more classical vimentin filament structures
in these cells. While the vimentin cytoskeletal network present in most cell types is insoluble to Triton X-100 detergent extraction
(Osborn and Weber, 1977; Blikstad and
Lazarides, 1983; Gilbert and Fulton, 1985;
Soellner et al., 1985), vimentin protein that
is not organized into filaments, or present
in the short filament structures that often
appear as squiggles (Chou et al., 2007), is
Triton X-100 soluble. Using a differential detergent extraction approach, we compared
vimentin solubility in MCS-wounded explants at the time of injury to cells in ECZ at
D2 postwounding (Figure 4G). Cells were
extracted sequentially with a Triton X-100/
octyl glucoside buffer (Brown and Rose,
1992) that isolates soluble forms of vimentin, including unassembled unit or short vimentin filaments, and a 4% SDS-containing
buffer that extracts the highly insoluble vimentin cytoskeletal network. The extracted
proteins were separated by gel electrophoresis and Western blotted for vimentin
(Figure 4G). We immunoblotted for the Triton-soluble protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as control.
The Western blot results were quantified
and represented graphically as percentage
of total vimentin that is soluble (Triton/OG)
and insoluble (SDS) (Figure 4G). While at the
time of wounding, vimentin was largely
present as a detergent-insoluble cytoskeletal network, at D2 postinjury in the ECZ,
vimentin had become highly soluble, with
the majority of the vimentin protein fractionating together with GAPDH in the Triton
X-100/OG extracts (Figure 4G). This high
level of soluble vimentin was consistent with
the diffuse labeling for vimentin observed in
the leader cell population of the ECZ (see
Figure 4D).

Posttranslational modification of
vimentin following injury

We investigated the possibility that posttranslational modifications (PTMs) of vimentin linked to vimentin solubility, including
citrullination and phosphorylation (Ando
et al., 1989; Inagaki et al., 1989; Sihag et al.,
2007; Hyder et al., 2008; Snider and Omary,
2014; Gudmann et al., 2015), were associated with the repair-modulating leader cell population activated by MCS injury. The presence of citrullinated proteins in MCS-wounded-explant cultures
Molecular Biology of the Cell

FIGURE 5: Citrullinated vimentin is detected postinjury and associated with repair-modulating
leader cells. (A) Proteins from D2 MCS-wounded-explant cultures were extracted,
immunoprecipitated with a citrulline antibody, and immunoblotted for vimentin. The results
showed the presence of vimentin in these citrulline immunoprecipitates. Whole cell lysates
(WCL) of MCS-wounded explants were immunoblotted for vimentin as a control. (B) Lysates of
cells in the ECZ regions at D2 postwounding were immunoblotted for citrulline and reprobed for
vimentin. Results shown for two independent studies (ECZ1 and ECZ2) demonstrate that
vimentin comigrates with the principal citrullinated band at 55 kDa (arrow), supporting the
conclusion that vimentin is citrullinated in cells of the ECZ. GAPDH is shown as a loading control.
(C–H) MCS-wounded explant cultures were coimmunolabeled at D2 postinjury with antibodies
to citrulline (C, E, F, H) and vimentin (D, E, G, H). The cultures were imaged in the ECZ by
confocal microscopy (C–E), and at the leading edge of the same ECZ by superresolution
confocal microscopy (F–H). While citrullinated proteins localized throughout the ECZ, they were
enriched in leading edge cells, including many regions where citrulline colocalized with vimentin.
(I) Proximity ligation assay (PLA) was performed in the ECZ at 2 d postinjury with antibodies to
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was examined using an immunoprecipitation approach. At 2 d postinjury, protein
extracts were immunoprecipitated with antibody to citrulline and the immunoprecipitated, citrullinated proteins immunoblotted
for vimentin (Figure 5A). The results showed
that vimentin is present in these citrulline
immunprecipitates, indicating that vimentin
is citrullinated in the MCS-wounded-explant cultures. Next, we extracted the proteins from the ECZ region at D2 postinjury,
electrophoretically separated the proteins,
immunoblotted the ECZ extracts for the citrulline PTM, and reprobed for vimentin
(Figure 5B). This study demonstrated the
citrullinated protein of greatest abundance
migrated at 55 kDa and was labeled with
antibody to vimentin; this supports the conclusion that vimentin is citrullinated in cells
that form the ECZ postwounding.
Next, cell-based studies were performed
to examine the localization of citrullinated
proteins in ECZ region at D2 postwounding.
The cultures were coimmunolabeled for citrulline and vimentin (Figure 5, C–H). While
there are citrullinated proteins throughout
the ECZ, they are enriched in the cells at the
leading edge (Figure 5, C–E). Superresolution confocal imaging of the protrusions
extended along the substrate by the leader
cells of the ECZ showed coincident immunolabeling of citrulline with a subset of the
vimentin protein in these cells (Figure 5,
F–H). To further examine vimentin citrullination in the lamellipodial protrusions of the
leader cells in the ECZ we performed a
proximity ligation assay (PLA) with antibodies to vimentin and the citrulline PTM and
postlabeled the cells for F-actin. The results
showed a strong vimentin/citrulline PLA signal specific to the cells at the leading edge
of the ECZ (Figure 5I).
Another PTM associated with vimentin
solubility is its phosphorylation at sites
such as Ser38. Immunolabeling for pSer38-
vimentin at D2 post-MCS wounding showed
that pSer38-vimentin+ cells were associated
with cells remaining on the wounded explant but that there were very few pSer38vimentin+ cells at the leading edge of the
ECZ (Supplemental Figure 2). As there are
multiple potential sites for vimentin phosphorylation, phosphorylation PTM cannot
vimentin and citrulline and then the cultures
were labeled for F-actin with fluorescentconjugated phalloidin. A positive PLA signal
(red) was detected in the lamellipodia tips of
the leading-edge cells of the ECZ, shown at
two levels of magnification. Mag bars, C–H,
and low-magnification image in I = 20 µm. In
high-magnification images in I the Mag bar =
10 µm; images are presented as projections.
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be ruled out as a factor in regulating vimentin organization and function in the leader cells of the ECZ.

On injury extracelluar vimentin is released into the
extracellular space and associated with the surface of
wound-activated leader cells and their underlying matrix
substrate
Although best known as a component of the intermediate filament
cytoskeleton, vimentin has also been shown to function as an extracellular protein. In this form, vimentin binds to the cell surface at
distinct sites, including specific cell-surface receptors, where it initiates a cellular response (Garg et al., 2006; Shigyo et al., 2015).
Among the roles identified for extracellular vimentin are the regulation of 1) immune cell function (Mor-Vaknin et al., 2003), 2) viral/
bacterial entry into cells (Koudelka et al., 2009; Chi et al., 2010; Das
et al., 2011; Liang et al., 2011; Du et al., 2014; Mak and Bruggemann, 2016; Yu et al., 2016), and 3) tumor progression (van Beijnum
et al., 2006; Satelli and Li, 2011). In studies with our clinically relevant MCS-injury model, we examined whether extracellular vimentin
was also a factor in the tissue response to wounding. We began with
an immunoblot analysis of conditioned media collected from the
MCS-wounded-explant cultures at D1 postinjury, which showed that
on injury vimentin was released into the culture media during the
repair process (Figure 6A). Medium alone does not contain vimentin. Since in a previous study we found no evidence of cell death
following MCS (Walker et al., 2010), we considered this an unlikely
source of the vimentin released into the medium. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay analysis performed at D1 postinjury showed that very few cells were
TUNEL positive in the MCS-wounded-explant cultures (Supplemental Figure 3), supporting this conclusion. These findings imply that
the release of vimentin into the media is an active process of the
wounding-healing response.
The impact of extracellular vimentin on cell behavior following
wounding is expected to involve its association with the cell surface.
To determine whether vimentin is on the surface of cells, we labeled
the cells within the ECZ with a cell-impermeable biotinylation reagent at D2 postwounding. Labeling with fluorescent-conjugated
streptavidin, which directly binds to biotin, confirmed that the biotin
label in this study was limited to the cell surface (Figure 6B). Following biotinylation, the ECZ cells were extracted and their biotintagged surface proteins isolated on an avidin column. The isolated,
biotin-tagged proteins were immunoblotted for vimentin (Figure
6C), for the surface receptor N-cadherin (positive control), and for the
cytoplasmic proteins GAPDH and Akt (negative controls) (Figure 6C).
The results showed that extracellular vimentin was linked to the surface of cells in the ECZ. Cell-surface-linked vimentin may associate
directly with the cell surface as it is released from the cells or become
associated with the cell surface after it is released to the medium.
To determine whether there was cell-type specificity of vimentin
cell-surface association, MCS-wounded-explant cultures were fixed
with paraformaldehyde and not permeabilized prior to immunolabeling for vimentin. We examined both the MCS wound edge on
the native basement membrane capsule (Figure 6E) and the leading
edge of the cells migrating across the ECZ (Figure 6F) by confocal
imaging for the presence of cell-surface–associated vimentin. The
results show that extracellular vimentin was bound exclusively to the
wound-activated repair cells at the leading edge of both the MCS
wound and the ECZ. Z-stacks collected at high magnification in the
ECZ revealed that extracellular vimentin was widely distributed all
along these cells’ basal surfaces, with higher levels at the filopodia/
lamellipodial processes extended at the cells’ periphery (Figure 6H).
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At these cells’ apical domains, extracellular vimentin was mostly
located to the surface of the filopodia/lamellipodial processes
extended between the cells (Figure 6G).
Using a biochemical approach, we investigated if vimentin released in response to wounding was associated with matrix substrate
underlying the leader cells in the ECZ. For this study, the wounded
explants were detached from the tissue culture substrate and the
ECZ cells removed by gentle scraping at D2 postinjury, leaving behind proteins linked to the substrate surface of the ECZ. These substrate-associated proteins were extracted and immunoblotted for
vimentin, which was shown to be a component of this protein fraction (Figure 6I). Immunoblotting for GAPDH confirmed that these
substrate-associated extracellular lysates were largely cell free. In
parallel, extracts from the wounded explants that were detached
from the dish were immunoblotted for vimentin and GAPDH. In a
different approach, the cells in the ECZ were exposed to the membrane-impermeable cross-linker bis (sulfosuccinimidyl) suberate (BS3)
at D2 postinjury to link cell-surface–associated proteins to proteins in
their ECM microenvironment. After radioimmunoprecipitation assay
(RIPA) buffer extraction of cellular proteins the extracellular proteins
were coimmunolabeled for vimentin and the ECM protein tenascinC that forms a provisional matrix on the underlying substrate of ECZ
cells migrating in response to wounding. Tenascin-C has been implicated in the induction of fibrosis (Kasprzycka et al., 2015; Bhattacharyya et al., 2016; Fu et al., 2017). Confocal imaging showed codistribution of tenascin-C and vimentin on the substrate surface in an area
underneath the leader cells of the ECZ (Figure 6, J and K). No F-actin
was detected in these cross-linking/extraction studies (Figure 6L).

Extracellular vimentin signals leader cell behavior in
response to wounding and the differentiation of these
cells to a myofibroblast phenotype
Our results showed that a soluble, extracellular, vimentin pool was
released by the cells into the culture medium during the repair process, so we examined whether the timing of myofibroblast emergence could be enhanced by the addition of soluble vimentin into
the explant culture medium. Those results showed that increasing
the concentration of vimentin over that produced by the cells did
not alter the timing of myofibroblast emergence or significantly alter
the degree of myofibroblast induction in this clinically relevant
wound-repair culture model (Supplemental Figure 4). Therefore, we
examined the functional roles of extracellular vimentin produced by
the cells in response to MCS wounding in both wound repair and
the induction of fibrosis. For these studies, the wounded cultures
were grown in the presence of monoclonal antibodies to vimentin.
To analyze effects on wound closure and emergence of myofibroblasts, we used two distinct vimentin antibodies, AMF17B and H5,
with IgG of the same isotype as control. In our previous studies, we
have shown that wound closure on the native substrate of the basement membrane capsule is typically complete by D3 post-MCS
(Menko et al., 2014a,b). For these studies, antibodies to vimentin
were added to the explant cultures at the time of wounding (D0),
the cultures imaged daily through culture D3, and open-wound area
quantified. Wound repair in the presence of the vimentin antibodies
slowed wound closure (Figure 7A), with dynamics and phenotype
similar to what we observed previously with small interfering RNA
vimentin knockdown (Menko et al., 2014a).
To investigate whether extracellular vimentin regulates leader
cell function in the ECZ and signals differentiation of leader cells to
myofibroblasts, we exposed the cells in the ECZ to antibodies to
vimentin from D1 postinjury, after removing the original lens explants from the culture dish, and examined them for effects on
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leader cell behavior and emergence of myofibroblasts at D3 in
culture. Both vimentin antibodies suppressed the extension of
lamellipodial processes by the leader cells and interfered with the
movement of leader cells across the ECZ (Figure 7B). The H5 monoclonal antibody (mAb) had a more potent effect on lamellipodia extension than AMF17B. Biochemical analysis revealed that blocking
the extracellular vimentin signal inhibited expression of the myofibroblast protein αSMA by cells in the ECZ, with H5 being slightly
more efficacious at blocking αSMA expression than AMF17B (Figure
7C). Immunolabeling confirmed that these vimentin antibodies suppressed the differentiation of leader cells to αSMA+ myofibroblasts
(Figure 7, E and F and H and I). The isotype IgG control had no effect on either cell migration or the development of fibrosis (Figure 7,
D and G). We also treated the ex vivo MCS cultures with low doses
of Withaferin A (WFA), which targets vimentin-soluble pools to inhibit vimentin function (Bargagna-Mohan et al., 2013) but can also
have off-target effects (Vanden Berghe et al., 2012). We found that
WFA, added to the media at D1 postinjury, decreased soluble pools
of vimentin, altered the motility of the leader suppressing the extension of lamellipodial protrusions along the substrate surface, and
blocked emergence of αSMA+ myofibroblasts in a dose-dependent
manner (Supplemental Figure 5). Together, these studies show that
the extracellular population of vimentin has the potential to regulate
leader cell function in the repair process and to signal their differentiation to myofibroblasts.

DISCUSSION
Fate of mesenchymal repair cells is determined by their
microenvironment
In studies of wound repair, there is growing evidence that mesenchymal cell populations activated to direct regenerative repair
become the progenitors of the myofibroblasts that underlie the aberrant repair processes of fibrosis and scarring. We have discovered
that the cytoskeletal protein vimentin, which is essential to the normal function of these repair-modulating cells in tissue regeneration,
can tip the balance from regenerative to fibrotic repair when these
cells encounter a profibrotic microenvironment. Our studies examined this dichotomous role for repair cells in the clinically relevant ex
vivo MCS wound-repair/fibrosis culture model. In their native microenvironment of the lens basement membrane capsule, these vimentin-rich mesenchymal repair cells rapidly migrate to the leading
edge of the MCS wound where they direct lens epithelial tissue
repair in a vimentin-dependent manner. When these same repair
cells move to the outside edges of the MCS explant cut to flatten
the lens capsule on the substrate, they lead lens-epithelial cells off
the lens capsule onto and across the culture dish, where these
vimentin-rich leader cells are induced to differentiate to αSMA+
myofibroblasts, the cell type associated with fibrotic disease. This
same change in cell phenotype was induced when these repair cells
encounter a collagen gel microenvironment whose stiffness is in the
physiological range of fibrotic tissues.

Cell-surface–associated vimentin is a factor in determining
repair cell fate and function
In our wound healing/fibrosis model, using vimentin antibodies
that blocked the function of extracellular vimentin, we found that
vimentin plays a role in promoting fibrosis beyond its classically
described structural functions. Our studies show for the first time
that an extracellular, cell-surface–associated vimentin population
released in response to injury is linked specifically to the woundactivated mesenchymal repair cells that localize to the leading
edge of the MCS wound. This extracellular vimentin pool is required
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for the function of these mesenchymal leader cells in directing the
regenerative repair process in the cells’ native basement membrane microenvironment (modeled in Figure 8). Our data suggest
that the fate of these cells is altered to that of a myofibroblast
when they associate with a profibrotic ECM microenvironment. This
interaction has the potential to signal a change in cell fate to a
myofibroblast and alter the function of these repair cells from proregenerative to agents that promote fibrotic disease. It is possible
that this extracellular vimentin population functions by binding to a
putative receptor for extracellular vimentin located on the cell
surface of the repair cells.

Corrleation between vimentin solubility and citrullination
following injury
A high percentage of the vimentin pool in the cells of the ECZ
following wounding was Triton/OG detergent soluble, contrasting
the highly detergent-insoluble vimentin cytoskeletal network of the
lens before wounding. Detergent insolubility is a feature of this
intermediate filament protein typical of most cell and tissue types
(Osborn and Weber, 1977; Blikstad and Lazarides, 1983; Gilbert and
Fulton, 1985; Soellner et al., 1985). It is likely that the soluble pool
of vimentin in the ECZ includes both cytoplasmic and extracellular
forms of this protein. Our data suggest that maintaining a large,
soluble pool of vimentin in response to the MCS wound is important
to the mechanism by which the mesenchymal leader cells function
in directing regenerative repair.
Vimentin solubility is typically associated with PTMs of this protein, with both citrullination and phosphorylation believed to be
primary PTMs that lead to and/or maintain vimentin protein-soluble
states (Ando et al., 1989; Inagaki et al., 1989; Sihag et al., 2007;
Hyder et al., 2008; Snider and Omary, 2014). Our studies show that
vimentin citrullination was a feature of the mesenchymal leader
cells located at the leading edge of the cells migrating across the
ECZ. This finding is interesting in light of evidence that suggests
citrullinated forms of vimentin play a role in fibrosis, including a report that patients with fibrosis express PAD enzymes that catalyze
vimentin citrullination (Abdeen and Olusi, 2010; Gudmann et al.,
2015) and the finding that patients with fibrosis produce antibodies
to citrullinated vimentin (Abdeen et al., 2011; Vassiliadis et al.,
2012, 2013).

Dynamic differences in vimentin and actin cytoskeletal
organization in proregenerative and profibrotic
environments
The lamellipodial protrusions that the mesenchymal leader cells extend along the rigid substrate of the ECZ were rich in vimentin, with
a high level of the vimentin labeling of these cells appearing diffuse.
This immunolabeling pattern likely represents a concentration of
soluble forms of vimentin, which could include unassembled vimentin protein, and unit or short vimentin, likely including vimentin that
is released to their cell surface. A distinguishing feature of the mesenchymal repair cells is the assembly of actin stress fibers in the
more rigid ECZ microenvironment, but not when these cells populate the MCS wound edge on their native basement membrane. It
has been shown that the presence of an organized vimentin intermediate filament cytoskeletal network can negatively regulate Rho
activity and block both actin stress fiber formation and myosin contractility (Jiu et al., 2017). This suggests that there is a dynamic,
coordinated regulation of cytoskeletal elements in these cells and
indicates that the predominance of soluble vimentin forms may
be necessary to establish the contractile phenotype of αSMA+
myofibroblasts.
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FIGURE 6: Extracellular vimentin is released in response to injury, associated with the cell surface of leader cells and
localized along the ECM substrate beneath the cells. (A) Conditioned media was collected from ex vivo MCS cultures at
1 d postinjury and immunoblotted for vimentin. The results show that an extracellular form of vimentin is released in the
media. No vimentin is present in culture media prior to exposure to the cells. (B) Cell surface proteins in the ECZ were
biotinylated at culture D2 and fixed and the biotin label was tagged with fluorescent-conjugated streptavidin. The
results showed that biotin labeling is restricted to the cell surface of cells in the ECZ. (C) Cell surface proteins in the ECZ
were biotinylated at culture D2, extracted, and immunoblotted for vimentin, N-cadherin (positive control), and GAPDH
and Akt (negative controls). The results demonstrated that extracellular vimentin is associated with the surface of cells in
the ECZ. (D–H) Paraformaldehyde fixed but not permeabilized ex vivo wounded cultures were immunolabeled for
vimentin to examine cell type specificity for extracellular-surface–associated vimentin at both the MCS wound edge
(D, arrow) and the leading edge of the ECZ (D, arrowhead). Cell-surface vimentin localized exclusively to leader cells of
both the native BM capsule (E) and in the ECZ (F). Boxed region in F is shown at higher magnification along apicolateral
(G) and basal (H) aspects of the cells. While extracellular vimentin was most prominent on cellular protrusions at the
apicolateral surface of the leader cells in the ECZ, the extracellular vimentin pool localized all along the cells’ basal
surfaces of these cells where they contact the extracellular matrix and to basal membrane extensions between cells.
(I) To determine whether basal extracellular vimentin also was associated with the substrate beneath the cells, cell-free
extracts of substrate-associated proteins were examined by Western blot. Extracts of isolated ex vivo explants were
included as a control (WCL). Results show that extracellular vimentin is associated with the proteins on the substrate.
Immunoblotting for GAPDH confirmed that extracellular lysates were largely cell free. Results are representative of
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On injury vimentin is released into the extracellular space
Our discoveries that extracellular vimentin is released in these
wound-repair cultures in response to injury, that it associates with
the cell-surface of repair-modulating cells, and that it mediates the
differentiation of the leader/repair cells to myofibroblasts are important new findings. The mechanism of vimentin release is not yet
clear. While vimentin lacks a classic secretory signal sequence, it is
secreted by macrophages in response to both pro- and anti-inflammatory cytokines (Mor-Vaknin et al., 2003). The release in exosomes
is another potential source for the extracellular vimentin pool (Chen
et al., 2016). Our own studies of the invasive potential of these
wound-activated repair cells have shown that when these cells
migrate through three-dimensional Matrigel, they are surrounded
by vimentin concentrated in puncta that could represent vimentincontaining vesicles (Bleaken et al., 2016).

Potential mechanisms of extracellular vimentin function
While extracellular vimentin has been localized to the cell surface of
different cell types, including macrophages (Mor-Vaknin et al.,
2003), endothelial cells (Xu et al., 2004; Zou et al., 2006; Koudelka
et al., 2009; Glaser-Gabay et al., 2011), neutrophils (Moisan and
Girard, 2006), astrocytes (Teshigawara et al., 2013), and circulating
tumor cells (Satelli et al., 2014, 2016, 2017), its extracellular function
has been poorly understood. In the mesenchymal repair cells that
populate the leading edge of the ECZ of our MCS-wounded cultures, extracellular vimentin was most highly localized to the cells’
basal surfaces (see model, Figure 8). Vimentin could mediate signaling binding to cell-surface receptors, transmitting a mechanotransduction signal that leads to the change in cell fate associated with
fibrosis. In support of this hypothesis, studies have reported that vimentin can act as a ligand for cell-surface receptors, such as CD44
(Pall et al., 2011) and IGF-1R (Garg et al., 2006; Shigyo et al., 2015).
While future studies will be aimed at elucidating the mechanisms by
which extracellular vimentin signals myofibroblast differentiation,
our current studies show that the microenvironment is a critical
driver of the function of the extracellular pool of vimentin. In wound
repair, the microenvironment determines whether vimentin associated with the surface of the mesenchymal cells activated on wounding promotes their role in regenerative repair or their transition to
myofibroblasts associated with fibrosis.

MATERIALS AND METHODS
Ex vivo MCS explant cultures
Ex vivo MCS explant cultures were prepared as previously described
(Walker et al., 2007, 2010, 2015; Menko et al., 2014a,b). Cells were
cultured in complete media (Media 199) (Invitrogen, Carlsbad,
CA) that included 1% penicillin/streptomycin (Mediatech-Cellgro,
Manassas, VA), and 1% l-glutamine (Mediatech-Cellgro) with 10%
fetal calf serum (Invitrogen). The mock cataract surgery is performed
after lenses are removed from E15 chick embryos (Poultry Futures,
Lititz, PA) to ex vivo culture. This microsurgical procedure removes
the fiber cells that comprise the mass of lens tissue (Walker et al.,
2007, 2015), leaving the basement membrane that surrounds the
lens in vivo as a capsular bag structure containing only the wounded

lens epithelial cells and a subpopulation of vimentin-rich mesenchymal repair cells (Walker et al., 2010; Menko et al., 2014a). The lens
epithelium and subpopulation of mesenchymal repair cells associated with the lens capsule are placed on tissue plastic cell side up.
By making cuts in the anterior aspects of the lens capsule, we flatten
the postcataract surgery lens capsular bag with its lens epithelial
and mesenchymal repair cells still attached. The resultant starshaped, flattened explants are placed on the culture dish, cell side
up (Figure 1A). The wounded lens epithelial cells are located at the
points of the star, surrounding the denuded lens capsule in the
center of the explants where the fiber cells had been attached
(Figure 1A, asterisk).
Since differentiation to myofibroblasts is promoted in a rigid extracellular environment (Tomasek et al., 2002; Hinz, 2007; Carver
and Goldsmith, 2013), we studied myofibroblast emergence in cells
that migrate from the outside cut edges of the ex vivo MCSwounded-explant cultures onto and across the rigid microenvironment of the tissue culture plastic (Figure 1, A and B). The lens
epithelial cells are led off the lens capsule by vimentin-rich mesenchymal cells that had rapidly migrated to the outside cut edge of
the capsule in response to the cut wound. We refer to the region just
beyond the lens capsule as the ECZ, the cells of which provide an
ideal reductionist model with which to study how cells critical to
regulating injury repair can be induced to change their fate and
become the myofibroblasts that underlie fibrosis.
For collagen gel substrate studies, MCS-wounded-explant cultures were placed directly on tissue culture dishes coated with 1 ml
of 2.5 mg/ml rat tail collagen I gels, according to the manufacturer’s
instructions (Millipore, Billerica, MA). For Boyden Chamber invasion
studies, MCS-wounded-explant cultures were placed cell side down
on Matrigel-coated membrane filters in Matrigel-Transwell assays
(BD Biosciences, San Jose, CA, and Corning, Corning, NY). Serumfree media was placed in the upper chamber and serum-containing
medium to the lower chamber. The underside of the filters containing invaded cells was processed for immunostaining. Phase images
were acquired with a Nikon Eclipse Ti microscope using imaging
software (NIS Elements; Nikon). Time-lapse video was acquired using a Nikon Eclipse Ti microscope driven by image analysis software
(NIS Elements). For time-lapse studies the culture dishes were contained in a Tokai Hit stage-top incubator. Vimentin function was
blocked with vimentin monoclonal antibodies, H5 (10 µg/ml) or
AMF17b (20 µg/ml) (mAbs; Developmental Studies Hybridoma
Bank, Bank Iowa City, IA), with mouse IgG isotype antibody (20 µg/
ml) from Jackson Immunoresearch Laboratories (West Grove, PA) as
control. In supporting studies vimentin was blocked with the
0.5–1 μM Withaferin A (Tocris, Ellisville, MO) with the vehicle dimethyl sulfoxide (DMSO; Sigma Aldrich, St. Louis, MO) as control.
Fresh antibody or inhibitor was added each day. To determine the
effect of exogenous vimentin on myofibroblast differentiation, recombinant vimentin (catalogue no. 2105-VI-100 from R&D Systems,
Minneapolis, MN) was added to ex vivo cultures on day 1. For
proliferation analysis, cells were pulsed with EdU (Click-iT EdU
Imaging Kits; Invitrogen, Carlsbad, CA) for 2 h and analyzed according to the manufacturer’s instructions. TUNEL assay (catalogue

three independent experiments. (J–L) To directly view the substrate-linked extracellular vimentin, extracellular proteins
in the ECZ were cross-linked with the membrane-impermeable BS3 cross-linker, cells extracted with RIPA, and the
cross-linked proteins fixed and labeled for tenascin-C (TN-C; J), vimentin (K), and F-actin (L). The results show that
extracellular vimentin was associated with the extracellular matrix substrate organized beneath the leader cells of the
ECZ (J, K). No staining for F-actin was detected in the cross-linked/extracted cultures (L) confirming effective removal of
the cells. Mag bars B, E = 20 µm; F = 50 µm; G, H, J–L = 10 µm. Images in B, E, F, G, and H are presented as single
optical sections. Images in J–L are presented as projections.
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no. 12156792910) from Sigma Aldrich (St.
Louis, MO) was performed according to the
manufacturer’s instructions.

Sequential detergent extraction
As we have described previously (Leonard
et al., 2011; Menko et al., 2014a), for sequential extraction studies samples were
extracted with Triton X-100/octyl glucoside
(Triton/OG) extraction buffer (44.4 mM noctyl β-d-glucopyranoside, 1% Triton X-100,
100 mM NaCl, 1 mM MgCl2, 5 mM EDTA,
10 mM imidazole, pH 7.4). The Triton/OGinsoluble proteins were solubilized in 2×
sample buffer (125 mM Tris-HCl, 4% SDS,
20% glycerol, 2% β-mercaptoethanol, 0.5%
bromophenol blue). To determine the relative distribution of Triton/OG soluble and
insoluble proteins the Triton/OG soluble
fractions were loaded at equal protein concentration and the SDS fractions were
loaded at volumes equal to the respective
Triton/OG soluble fractions.

Western blot analysis

FIGURE 7: Extracellular vimentin mediates leader cell behavior associated with wound healing
and their transition to myofibroblasts. To examine the role of extracellular vimentin in both
wound repair and fibrosis, the MCS-wounded-explant cultures were grown in the presence of
two distinct antibodies to vimentin, AMF7b, and H5 or in the presence of a nontargeting IgG of
the same isotype as control. (A) For the wound-healing studies, the MCS explants were treated
with the vimentin antibodies from the time of wounding (D0) through D3, by which time the
wound is typically healed. Open wound area was quantified each day and the results presented
graphically. Representative phase-contrast images are shown at culture D3 (double arrow
indicates open wound area). The presence of either vimentin antibody during wound-repair
slowed wound closure. (B–I) Isolated ECZ regions were exposed to the vimentin antibodies
(AMF17b and H5) or IgG isotype control for 2 d beginning at D1 postinjury to determine the
effect of blocking extracellular vimentin function on myofibroblast emergence. (B) Phasecontrast imaging showed that lamellipodia extension at the leading-edge of the ECZ was
impaired by treatment with either the AMF17B or the H5 vimentin antibodies (see arrows).
(C) Total cell lysates prepared from ECZ regions exposed to AMF17B, H5, or isotype control
antibodies were immunoblotted for αSMA and GAPDH, the results quantified and presented as
a ratio of αSMA to GAPDH. This study showed that exposure to either of the vimentin
antibodies inhibited emergence of αSMA+ myofibroblasts. (D–I) ECZ cells were treated with
either the vimentin antibody AMF17b, the vimentin antibody H5, or an isotype-specific IgG
beginning at D1 postinjury and fixed at culture D3. The cultures were immunolabeled for αSMA
(D–I, red in G–I) and colabeled for F-actin (G–I, green). Emergence of αSMA+ myofibroblasts at
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Samples were extracted in Triton/OG except
for studies of α-SMA expression for which
the cells were extracted in RIPA buffer (5 mM
EDTA, 150 mM NaCl, 1% NP40, 1% sodium
deoxycholate, 1% SDS 20% solution, 50 mM
Tris-HCl, pH 7.4) containing protease/phosphatase inhibitor cocktail (Cell Signaling,
Danvers, MA). All protein concentrations
were determined by a BCA protein assay
(BCA Assay; Pierce, Rockford, IL). All proteins
were separated on Tris-glycine gels (Novex,
San Diego, CA), under reducing conditions
followed by electrophoretically transferring
to membranes (Immobilon-P; Millipore), and
subsequently immunoblotted as described
previously (Walker and Menko, 1999). Enhanced chemiluminescence (ECL) and ECL
Plus Western blotting substrate (Pierce; ThermoFisher, Waltham, MA) were used for detection. Antibodies used for Western blotting (see Table 1) included vimentin (AMF17b
mAb; Developmental Studies Hybridoma
Bank, Iowa City, IA), vimentin polyclonal antibody (a generous gift from Paul FitzGerald,
University of California, Davis, CA), GAPDH
(catalogue no. sc-25778) from Santa Cruz
Biotechnology (Santa Cruz, CA), α-smooth
muscle actin (catalogue no. ab5694) from
Abcam (Cambridge, United Kingdom),
N-cadherin (catalogue no. 610921) from BD

the leading edge of the ECZ was inhibited by
blocking extracellular vimentin function.
p values generated by Student’s t test
***p < 0.001. Mag bar B = 10 µm and D–I =
20 µm. Images in D–I are presented as
projection images.
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FIGURE 8: Model depicting differences in vimentin and actin cytoskeleton organization in mesenchymal leader cells in
proregenerative and profibrotic environments. The mesenchymal leader cells that locate to the wound edge in a
proregenerative environment organize an extensive vimentin intermediate filament cytoskeleton that extends into the
cells’ lamellipodial processes. These repair-modulating cells are remarkably poor in actin stress fibers. The cytoskeletal
organization is altered when these mesenchymal leader cells migrate into a profibrotic environment. Here, these cells
organize extensive actin stress fibers and vimentin is most striking for its high expression in the cells’ lamellipodia where
it is present in a diffusely organized form. On injury, vimentin is also released to the extracellular space and becomes
linked to the cell surface of the mesenchymal repair cells at the leading edge of both environments where it plays a role
in both wound repair and altering these cells’ fate to myofibroblasts.

Biosciences (San Jose, CA) and Akt (catalogue number 9272) from
Cell Signaling (Danvers, MA). Densitometry analysis was performed
using AlphaView Software (Protein Simple; San Jose, CA). α-SMA
expression in the time course is presented as a ratio to GAPDH. For
the WFA and vimentin antibody studies results were normalized to
control and presented as a ratio to GAPDH. Sequential detergent
extractions are shown as the percentage of total vimentin in each
fraction. Histograms are shown ± SEM, with p values generated by
Student’s t test.
Antibody name

Cell-surface biotinylation
For biotinylation of cell-surface proteins we used the Cell Surface
Protein Isolation Kit (Pierce; ThermoFisher, Waltham, MA) according to manufacturer’s directions. Briefly, cells were incubated with
the membrane-impermeable Sulfo-NHS-SS-Biotin reagent. After
the reaction was stopped, cells were gently scraped, lysed, and
transferred to a NeutroAvidin agarose column for isolation of
biotin-labeled cell-surface proteins. Finally, biotin labeled cell-surface proteins were eluted from the column using DTT solution and

Source

Product number

Dilution factor

Alpha smooth muscle actin

Millipore Sigma

CBL171

1/200 (IF)

Alpha smooth muscle actin

Abcam

Ab5694

1/100 (IF); 1/1000 (WB)

Akt

Cell Signaling

9272

1/1000 (WB)

CD44

Developmental Studies Hybridoma Bank (DSHB)

1D10

1/10 (IF)

Citrulline

Abcam

Ab6464

1/100 (IF)

Citrulline

Millipore Sigma

MABN328

1/200 (IF); 1/500 (WB)

GAPDH

Santa Cruz

Sc-25778

1/1000 (WB)

N-cadherin

BD Transduction Lab

610921

1/2000 (WB)

Tenascin

Millipore Sigma

AB19013

1/200 (IF)

Vimentin

DSHB

AMF17B

1/10 (IF); 1/100 (WB)

Vimentin

DSHB

H5

1/10 (IF)

Vimentin

Abcam

Ab92547

1/2500 (WB)

Vimentin (phosphoS38)

Abcam

Ab52942

1/100 (IF)

Vimentin

Gift, Paul FitzGerald, University of California, Davis

1/100 (IF)

TABLE 1: Antibody sources, product numbers, and dilutions used in these studies.
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SDS–PAGE buffer and analyzed by Western blot analysis. Biotin
labeled cultures were also fixed and labeled with a fluorescentconjugated streptavidin (catalogue no. 21832) from Invitrogen
(Carlsbad, CA) to confirm that biotin labeled cell surfaces.

quenched with (50 mM Tris-HCl), and the cells were extracted with
RIPA buffer containing protease/phosphatase inhibitor cocktail (Cell
Signaling, Danvers, MA) and the substrate-associated proteins fixed
with 3.7% formaldehyde in PBS.

Immunofluorescence
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Immunostaining of epithelial explants was performed as previously
described (Walker et al., 2007, 2010). Briefly, prior to immunostaining, explants were fixed in 3.7% formaldehyde in phosphatebuffered saline (PBS) and permeabilized in 0.25% Triton X-100
(Sigma-Aldrich) in PBS. For immunostaining of nonpermeabilized
cells to detect only surface proteins cultures were fixed with either 1
or 2% methanol-free paraformaldehyde, as indicated. The following
primary antibodies were used for the immunofluorescence studies
(see Table 1): vimentin (H5 and AMF17b mAb; Developmental Studies Hybridoma Bank, Iowa City, IA), vimentin polyclonal antibody (a
generous gift from Paul FitzGerald), vimentin polyclonal antibody
(catalogue no. ab92547) from Abcam (Cambridge, MA), CD44
(1D10 mAb, Developmental Studies Hybridoma Bank, Iowa City,
IA), tenascin-C (catalogue no. AB19013) from Millipore (Burlington,
MA), pSerine 38 vimentin rabbit (catalogue no. ab115150), αSMA
(catalogue no. ab5694), and citrulline antibody (catalogue no.
ab6464) from Abcam (Cambridge, MA), and a citrulline antibody
F95 (catalogue no. MABN328) from MilliporeSigma (Burlington,
MA). Cells were incubated with primary antiserum followed by
rhodamine-conjugated (Jackson ImmunoResearch Laboratories and
Millipore), fluorescein-conjugated (Jackson ImmunoResearch Laboratories, Westgrove, PA), or Alexa Fluor 488–conjugated (ThermoFisher, Waltham, MA), secondary antibodies. As indicated, cells
were counterstained with Alexa Fluor 488–conjugated phalloidin,
Alexa Fluor 633 or Alexa Fluor 647 phalloidin (ThermoFisher,
Waltham, MA) to label filamentous actin (F-actin), and/or the nuclear
stain TO-PRO 3 (Invitrogen, Carlsbad, CA). To track the fate of CD44
leader cells to become myofibroblasts, cultures were live labeled
with CD44 antibody for 20 min. Antibody was removed and media
was replaced for 2 d subsequent to fixation and processing for immunostaining. Immunostained samples were examined by confocal
microscopy (LSM 510, LSM 800 with Super Resolution Airyscan,
Zeiss, Thornwood, NY). Single images or Z-stacks were collected
and analyzed; the data presented represent single optical planes or
maximal intensity projection images.
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Proximal ligation assay
To determine whether vimentin was citrullinated, we performed
proximal ligation assay (PLA) according to manufactures guidelines
(Duolink; Sigma-Aldrich). Briefly, fixed cultures were incubated with
antibody to citrulline (catalogue no. ab6464) from Abcam and vimentin antibody H5 from Developmental Studies Hybridoma Bank simultaneously, followed by PLA affinity probes for rabbit and mouse
(Duolink; Sigma-Aldrich) that binds to the target antibodies. Cells
were then incubated with Detection Reagents Red (Duolink; SigmaAldrich), which includes a ligation solution and a connecter oligonucleotide that hybridizes to the probes that allows amplification of
DNA to produce a signal to be detected by fluorescence imaging.

Cross-link extraction
To examine whether vimentin associated with the extracellular matrix deposited beneath the cells on the substrate, we performed
cross-link extractions as previously described (Enomoto et al., 1993).
Cells were then incubated with the cell-impermeable cross-linker
BS3 (ThermoFisher, Waltham, MA) in PBS with phenylmethylsulfonyl
fluoride (PMSF) protease inhibitor (Sigma-Aldrich). The reaction was
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